Northwest Biotherapeutics (NBYB) Revenue

0 Followers

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had a revenue of 807.00K in the quarter ending Jun 30, 2026, with 63.36%. This bring the company's revenue in the last twelve months to 2.17M, Decreased 45.16%. In the fiscal year ending Dec 31, 2025, Northwest Biotherapeutics had annual revenue of 1.38M with -0.29% growth.

Revenue (ttm)

2.17M

Revenue Growth

84.01%

P/S Ratio

173.86

Revenue/Employee

€13,124

Employees

105

Market Cap

€239.58M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.38M	-4.00K	-0.29%
Dec 31, 2024	1.38M	-550.00K	-28.47%
Dec 31, 2023	1.93M	249.00K	+14.80%
Dec 31, 2022	1.68M	678.00K	+67.46%
Dec 31, 2021	1.00M	-286.00K	-22.15%
Dec 31, 2020	1.29M	-1.12M	-46.43%
Dec 31, 2019	2.41M	2.00M	+484.95%
Dec 31, 2018	412.00K	76.00K	+22.62%
Dec 31, 2017	336.00K	―	―